Mitral Valve Diseases

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 21/06/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4601 times

2 Mitral Valve Diseases

Indications

The 2003 ACC/AHA/ASE (American College of Cardiology/American Heart Association/American Society of Echocardiography) Guideline Update for the Clinical Application of Echocardiography lists the various indications for TEE.1 Several of them apply specifically to the MV and they are listed in Table 2-1.

TABLE 2-1 INDICATIONS FOR MITRAL VALVE ASSESSMENT BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY

Class I

Conditions for which there is evidence for and/or general agreement that a procedure be performed or a treatment is of benefit. Class IIa Conditions for which there is a divergence of evidence and/or opinion about the treatment.
Weight of evidence/opinion is in favor of usefulness or efficacy. Class IIb Conditions for which there is a divergence of evidence and/or opinion about the treatment.
Usefulness/efficacy is less well established by evidence or opinion.

LA, left atrium; LA, left atrial; MR, mitral regurgitation.

From the 2003 ACC/AHA/ASE Guideline Update for the Clinical Application of Echocardiography.

Mitral Valve Anatomy (Figure 2-1)

image

Figure 2-1 MV anatomy.

Adapted from Otto CM. Evaluation and management of chronic mitral regurgitation. N Engl J Med. 2001;345:740-746. Reproduced with permission.

Systematic Examination of the Mitral Valve

Regardless of the type of MV disease, the TEE assessment always begins with a systematic two-dimensional (2D) examination of the valve. Using an organized sequence of cross sections, each scallop/segment of the MV is carefully examined for structure and function. The next section describes one sequence of views of the MV. It is important to remember that only the basic views are described here. With increasing experience, echocardiographers make great use of transition images, or images between standard views.

Sequence of Views (Table 2-2 and Figure 2-3)

Three-Dimensional Echocardiography

Three-dimensional (3D) TEE provides exceptional images of the heart. Instead of a plane of information, the computer acquires a volume of data, which can then be reconstructed and viewed from any angle (Figure 2-4). Moreover, the data set can be sliced in any desired plane, much like a computed tomography (CT) scan, in order to re-create 2D images sometimes impossible to obtain by standard 2D echocardiography (Figure 2-5).

The MV, because of its proximity to the TEE transducer, lends itself particularly well to 3D imaging. At this time, 3D remains an adjunct to 2D, but as more centers gain experience with this technology, 3D imaging will become an integral part of intraoperative MV assessment.

The mechanism of MR is usually readily apparent on 3D imaging. Furthermore, off-line MV analysis software packages allow detailed quantification of MV disease, including dimensions, prolapses, and restriction (Figure 2-6). This is very useful in planning the surgical management of MR and may help to identify patients who require specialized surgical care. Moreover, the development of leaflet stress analysis packages opens the door to the possibility of predicting, in the immediate post-bypass stage, the durability of some MV repairs.

Mitral Regurgitation

MR can be due to a structural problem in the valve itself or it may be due to distortion of the valve by external factors, described in Table 2-3.

TABLE 2-3 ETIOLOGY OF MITRAL REGURGITATION

Structural MR

Functional MR MR due to LVOT obstruction

HOCM, hypertrophic obstructive cardiomyopathy; LV, left ventricle; LVOT, left ventricular outflow tract; MR, mitral regurgitation.

Classification of Mitral Regurgitation

Based on leaflet motion: normal, excessive or restricted (Figure 2-7).

Evaluation of Mitral Regurgitation

Step 1: Determine the Mechanism and Localization of Lesions and Etiology

The TEE evaluation of MR requires a comprehensive structural examination of the MV, to determine the mechanism of MR and localization of lesions. This involves a detailed 2D examination described previously. In each cross section, the appearance and integrity of the leaflets is noted: Are the leaflets thickened or calcified? Are they redundant (too much tissue)? Are they intact? One also looks at leaflet motion: Is it normal, excessive, or restricted? The coaptation point is then examined; is it below, at, or above the annular plane? Is there lack of coaptation?

One then proceeds to color Doppler evaluation of the regurgitant jet(s) and spectral Doppler measurements. When available, 3D echocardiography is useful to supplement a comprehensive 2D examination, but in the vast majority of cases, it is not essential to making a diagnosis.

Severity of Mitral Regurgitation

Step 2: Qualitative Assessment

Color Flow Doppler

Color flow Doppler remains the best screening method to diagnose MR. It also allows a semiquantitative assessment of the severity of regurgitation and can provide clues to the mechanism of MR. Pitfall: The appearance of MR by color Doppler is highly dependent on the gain and Nyquist limit of the transducer. Setting the gain too high or the Nyquist limit too low can make the MR appear more severe.